English – Page 1249 – TechStock²

Today: 2 May 2026

Real-time market monitoring

New Gold Inc (NGD) Stock: 201% Rally, $7 Billion Coeur Mining Buyout and December 2025 Analyst Outlook

New Gold Inc. shares surged 201% over the past year, trading near C$11.37 on the TSX and US$7.80 on NYSE American as of December 11, 2025. The company posted record Q3 free cash flow of US$205 million and agreed to a $7 billion all-stock takeover by Coeur Mining. New Gold’s market cap stands at roughly US$6.2 billion, with analysts issuing unusually bullish “Buy” ratings.

11 December 2025

Mergers & Acquisitions·Mining Industry·NYSEA:CDE·NYSEA:NGD·Stock Market·TSX:NGD

Hecla Mining (HL) Stock Hits 52‑Week High as Silver Soars: December 2025 Outlook, Forecasts and Risks

Hecla Mining stock hit a 52-week high of $18.13 on December 11, 2025, capping a year-to-date gain of over 200%. The company’s market value now stands near $12 billion, as shares far outpaced silver prices and the broader market. Analysts remain divided, with most forecasts below the current price. Hecla operates major silver and gold mines in Alaska, Idaho, Quebec, and Yukon.

11 December 2025

Financial Forecasts·NYSE:HL·Silver

Polestar Automotive (PSNY) Stock Plunges After Reverse Split – Latest News, Analyst Forecasts and 2025–2026 Outlook

Polestar shares plunged over 20% Wednesday and slid further Thursday, trading near $12.45 after a 1-for-30 reverse stock split and a Nasdaq compliance warning. The stock hit a new 52-week low despite reporting nearly 50% revenue growth for 2025 so far. Technical analysts now rate PSNY a “Strong Sell,” projecting up to 46% more downside in the next three months.

11 December 2025

NASDAQ:PSNY·Stock Market

Wave Life Sciences (WVE) Stock on December 11, 2025: Obesity Breakthrough, 180% Rally, $350M Offering and Fresh Analyst Targets

Wave Life Sciences shares surged over 180% in a week after Phase 1 data showed its obesity drug WVE-007 reduced visceral fat by up to 10% and increased lean mass. The stock hit a five-year high near $22 before retreating to $17.06 following a $350 million equity offering and insider selling. Analyst price targets jumped, but Wave remains unprofitable with high valuation risk.

11 December 2025

Biotechnology·NASDAQ:WVE·Pharmaceutical Industry·Stock Market

Nuvation Bio (NUVB) Soars After $18 Price-Target Hike – Is This High‑Growth Cancer Stock Still a Buy in 2025?

Nuvation Bio shares surged nearly 200% year-to-date, trading around $7.84 on December 11, 2025, after FDA approval of its lung cancer drug IBTROZI and strong analyst upgrades. H.C. Wainwright raised its price target to $18, citing higher revenue forecasts and clinical results. Average daily volume reached 8.7 million shares. The company reported 204 new patients started IBTROZI in Q3.

11 December 2025

NYSE:NUVB

First Majestic Silver (AG) Blasts to a 52‑Week High as Silver Hits Records – Can the Run Last?

First Majestic Silver shares hit a 52-week high of $16.30 on December 11, trading near $16.50 intraday, after silver prices reached all-time highs. The stock is up about 185–190% year-to-date, lifting market cap to $7.5–8.0 billion. Q3 2025 saw record silver production of 3.9 million ounces and EBITDA of $128.6 million. Net earnings reached $43 million, reversing a loss from last year.

11 December 2025

NYSE:AG·Silver·Stock Market·TSX:AG

Oracle Stock Crashes 14% as Wall Street Slashes AI Price Targets

Oracle shares fell 13–14% on December 11, 2025, wiping out over $100 billion in market value after fiscal Q2 results. The company reported record capital spending of $12 billion and negative free cash flow, despite strong AI cloud revenue. Guidance missed expectations, prompting major Wall Street banks to cut price targets.

11 December 2025

NYSE:ORCL·Stock Market

Cisco (CSCO) Stock Outlook After November 21, 2025: AI Joint Ventures, Record Highs and Analyst Targets

Cisco shares hit a record closing high of $80.25 on December 10, surpassing their dot-com era peak. The stock is up about 36% in 2025, fueled by strong Q1 results, $1.3 billion in AI infrastructure orders, and new Saudi and Iraq network deals. Wall Street price targets now cluster in the mid-$80s, with some as high as $90.

11 December 2025

Artificial Intelligence·NASDAQ:CSCO·Stock Market·Technology

Applied Materials (AMAT) Stock Hits Record High: Is the AI Chip Boom Enough to Power 2026 Gains?

Applied Materials shares have surged over 20% since November 21, 2025, closing at $275.15 on December 10, a new 52-week high. The stock now trades near $267, up roughly 60–70% year-over-year, with a market cap above $210 billion. Q4 earnings beat estimates with $2.17 EPS and $6.80 billion revenue, despite a mild year-over-year decline. Management forecasts Q1 2026 revenue of $6.85 billion plus or minus $500 million.

11 December 2025

NASDAQ:AMAT

Centene (CNC) Stock Jumps on Baird Upgrade: What December 11, 2025 Means for the Outlook and Forecasts

Centene shares jumped above $40 on December 11, 2025, after Baird raised its price target to $36 but kept a neutral rating. The stock closed at $40.73, up 5.3%, extending a rebound from a summer marked by guidance cuts and a rare loss. CNC now trades about 62% above its 52-week low but remains 39% below its February high. The price is at or above most analyst targets, with consensus ratings still cautious.

11 December 2025

Financial Forecasts·NYSE:CNC

Caterpillar (CAT) Stock Near Record Highs on AI Data Center Boom: Latest News, Analyst Targets and 2026–2030 Forecasts

Caterpillar shares closed at $616.96 on December 11, up over 12% since November 21 and more than 60% in the past year. Q3 2025 sales reached $17.6 billion, led by a 31% jump in power generation revenue for data centers. Operating margin fell to about 17–18% due to tariffs and higher manufacturing costs. The stock trades near record highs, with a forward dividend yield under 1%.

11 December 2025

NYSE:CAT·Stock Market

Visa Inc. (V) Stock Forecast 2026: BofA Upgrade, Stablecoin Push and What’s Changed Since November 21, 2025

Visa shares climbed to $338.10 on December 11, up 3–4% on the day, but remain about 10% below their June 2025 record high. The move follows a Bank of America upgrade, analyst reports, and strong fiscal Q4 results, with EPS at $2.98 and net revenue at $10.7 billion, both above estimates. Trading volume and insider share activity have increased since November 21. Visa’s market cap stands near $593 billion.

11 December 2025

Cryptocurrency·NYSE:V·Stock Market

Spotify Stock (SPOT) Outlook 2026: Price Hikes, Music Videos and Wrapped 2025 Fuel a New Phase for Investors

Spotify shares traded near $603 on December 11, 2025, up about 36% year-to-date after surging 138% in both 2023 and 2024. Q3 results showed 713 million monthly active users and €899 million net income, with Q4 operating income guidance topping analyst estimates. The company plans further subscription price hikes and a push into music videos. Analysts remain bullish, though some warn on valuation.

11 December 2025

NYSE:SPOT

Citigroup (C) Stock Hits Fresh 52‑Week High After Major Shake‑Up: Latest News, Analyst Targets and 2026 Outlook

Citigroup shares hit a new 52-week high of $111.92 on December 11, following a leadership shakeup and U.S. consumer business reorganization announced November 21. The stock has climbed about 12–13% since then, with trading volume spiking to 16.4 million shares on December 10. Most analysts rate the stock a “Buy,” though price targets are now close to current levels.

11 December 2025

NYSE:C

Vera Therapeutics (VERA) Stock Outlook: December 11, 2025 Update on Public Offering, Atacicept BLA and Wall Street Targets

Vera Therapeutics shares traded near $46 on December 11, 2025, after announcing a $261 million stock offering at $42.50 per share. The company filed a Biologics License Application for atacicept in IgA nephropathy and reported strong late-stage clinical results. Shares are up nearly 100% in six months, with market cap around $2.9–3.0 billion. The offering is expected to close today.

11 December 2025

NASDAQ:VERA·Pharmaceutical Industry

UK Stock Market Today (11 December 2025): FTSE 100 Closes Higher Near Record Highs After Fed Cut as BoE Bets Build

The FTSE 100 closed at 9,711.47 on Thursday, up 0.6%, staying just below its record high set in November. The session followed a third straight US Federal Reserve rate cut and rising bets the Bank of England will ease policy next week. The FTSE 250 was flat, while AIM All-Share edged higher. Oracle shares fell 11% after weak results, fueling renewed concern over AI-linked tech valuations.

11 December 2025

FTSE 100·LSE:DRX·LSE:FGP·NASDAQ:ORCL·Stock Market

US Stock Market Today, December 11, 2025: Dow Climbs While Oracle-Led AI Sell-Off Hits Nasdaq After Fed Rate Cut

The Dow rose 0.6–0.9% by late morning Thursday, while the S&P 500 slipped 0.2–0.5% and the Nasdaq fell nearly 1% as investors sold off AI-linked stocks following Oracle’s 14% plunge. The split comes a day after the Fed cut rates for the third time in 2025 and the S&P 500 closed just below its record high.

11 December 2025

Federal Reserve·NASDAQ:ORCL·NYSE:DIS·Stock Market·US Economy

EU Stock Market Today, 11 December 2025: Cyclicals Rally While Tech Stumbles After Fed Rate Cut and SNB Hold

European stocks closed higher on December 11, with the STOXX Europe 600 up 0.66% and the Euro Stoxx 50 gaining 1.0%, as investors favored financials and cyclicals after the Fed’s rate cut. Germany’s DAX and Spain’s IBEX 35 hit new highs. Technology shares lagged, with SAP dropping up to 3% after Oracle’s weak outlook revived concerns over AI sector profits.

11 December 2025

BME:NTGY·EPA:SU·Federal Reserve·Stock Market·XETRA:DHER

Bitcoin Price Today, December 11, 2025: BTC Hovers Around $90K as Fed Cut and AI Jitters Test the Rally

Bitcoin traded near $90,000 on December 11, 2025, after swinging between $89,623 and $94,177. The price is down about 2–3% in 24 hours and roughly 14% over the past month, well below October’s record high. The drop follows a Federal Reserve rate cut and weak tech sentiment after Oracle’s outlook. Major cryptocurrencies also fell, with ETH and SOL down 4–6%.

11 December 2025

Bitcoin·Cryptocurrency·Federal Reserve·NYSE:ORCL

Coinbase Stock (COIN) Outlook After November 21: Analyst Targets, New Partnerships and Q3 Beat Shape the 2025–2026 Forecast

Coinbase shares traded near $268 midday December 11, down about 11% over the past month despite strong Q3 results and continued high crypto trading volumes. The company posted Q3 net earnings of $1.44 per share and $1.9 billion in revenue, both well above analyst estimates. Wall Street has adjusted price targets and ratings since November 21. Social media sentiment remains split amid market volatility and regulatory concerns.

11 December 2025

Cryptocurrency·Earnings Reports·NASDAQ:COIN

Previous 1 … 1,247 1,248 1,249 1,250 1,251 … 1,889 Next

Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan
May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could pressure margins. Forecasts project ¥1.38 trillion revenue and ¥517 billion earnings by 2028, implying modest growth. Analysts remain divided, with some optimistic on AI-driven pipeline advancements, while others caution on pricing and competitive threats. The governance changes highlight an evolving incentive model as Chugai navigates opportunities and challenges in biologics and Roche partnership dynamics.

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 02.05.2026

2 May 2026

LIVEMarkets rolling coverageStarted: May 2, 2026, 12:00 AM EDTUpdated: May 2, 2026, 1:38 AM EDT Chugai Pharmaceutical Reports Strong Q1 Earnings, Introduces Trust-Based Stock Plan May 2, 2026, 1:28 AM EDT. Chugai Pharmaceutical (TSE:4519) posted robust first-quarter 2026 earnings, with sales of ¥291.6 billion, revenue of ¥321.7 billion, and net income of ¥115.4 billion surpassing prior year levels. The company's board unveiled a trust-based stock compensation system to better align management incentives with performance amid rising R&D expenses and strategic collaborations. Despite near-term strength, investors face risks from patent expiries, biosimilars, and National Health Insurance (NHI) price revisions that could

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026

Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026

McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.

Go toTop

Stock Market Today

Latest article